Inhaler Corticosteroid Device Market
完整報告名稱與涵蓋範圍
Inhaler Corticosteroid Device Market Size, Share & Trends Analysis Report, By Steroid Types (Beclomethasone Dipropionate, Budesonide, Fluticasone Inhaler Powder, & Mometasone), By Application (Asthma, COPD (Chronic Obstructive Pulmonary Disease) and Others) By End-user (Hospitals and Clinics, Academic and Research Institutes and Respiratory Care Center), By Region, Forecasts, 2024-2031
報告摘要
Valued at USD 616.09 Mn as of 2023, the global Inhaler Corticosteroid Device Market is set to climb to USD 886.4 Mn by 2031, reflecting a compound annual growth rate of 4.6% over the 2024–2031 period.
Inhaler Corticosteroid Device covers a disease of the entire respiratory tract, including large, intermediate, and small airways. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Market momentum is propelled by escalating interest in advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Inhaler Corticosteroid Device Market Snapshot
Chapter 4. Global Inhaler Corticosteroid Device Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Steroid Types Estimates & Trend Analysis
5.1. by Steroid Types & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Steroid Types:
5.2.1. Beclomethasone Dipropionate
5.2.2. Budesonide
5.2.3. Fluticasone Inhaler Powder
5.2.4. Mometasone
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Asthma
6.2.2. COPD (Chronic Obstructive Pulmonary Disease)
6.2.3. Others
Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis
7.1. by End-user & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-user:
7.2.1. Hospitals and Clinics
7.2.2. Academic and Research Institutes
Chapter 8. Inhaler Corticosteroid Device Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Steroid Types, 2019-2031
8.1.2. North America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.1.3. North America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
8.1.4. North America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Steroid Types, 2019-2031
8.2.2. Europe Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.2.3. Europe Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
8.2.4. Europe Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Steroid Types, 2019-2031
8.3.2. Asia Pacific Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.3.3. Asia-Pacific Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
8.3.4. Asia Pacific Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Steroid Types, 2019-2031
8.4.2. Latin America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.4.3. Latin America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
8.4.4. Latin America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Steroid Types, 2019-2031
8.5.2. Middle East & Africa Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.5.3. Middle East & Africa Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
8.5.4. Middle East & Africa Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. -La Roche Ltd. (Switzerland)
9.2.3. Pfizer Inc.
9.2.4. GlaxoSmithKline plc
9.2.5. Novartis AG
9.2.6. Mylan N.V.
9.2.7. Teva Pharmaceutical Industries Ltd.
9.2.8. Sanofi
9.2.9. Boehringer Ingelheim International GmbH.
9.2.10. AstraZeneca
9.2.11. F. Hoffmann-La Roche Ltd.
9.2.12. Bristol-Myers Squibb Company
9.2.13. Amgen Inc.
9.2.14. Aurobindo Pharma
9.2.15. Eli Lilly and Company
9.2.16. Cipla Inc.
9.2.17. Sumitomo Corporation
9.2.18. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們